Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
About 60 trading days until data release... Kips has to average 350k daily sales to dump 20 million. Should be attainable as this drifts lower and lower...
Wake us up in mid August Leo!!! Going to be a long summer waiting for results that won't matter unless they get emergency use... Just another shelved Phase 2 compound... India cases reversing as vaccines get deployed...
We have an idea the largest seller of shares has been Aspire over 200 million since they started to fund IPIX followed by the MFO and soon to be Kips. Menon, Sullivan and Leo have to be in the top ten all-time. Don’t forget the Arudas who were handed millions of shares for the rights to K. Looking back they should have given K to the Arudas and saved the shares. Another worthless compound slowly losing its patent expirations.
Aspire dumped their shares ahead of Prurisol data and all the other trials. Their business model is to make profit not lose it all. Kips 4 million worth of stock hangs in the balance.
Yes, Those places will be receiving the vaccines the rest the year... Do you know when B will be approved? You think 120 subjects is enough data to treat those in high risk? Most who have CV19 won't need B only those in dire need... B needs great data and then emergency use... What's the odds? 20 pennies per/share?
Why would they have to unload by now if their cost basis is 12 pennies? Sure, it made sense to unload at a higher price but now have 8 to 10 weeks to make a decision... Doubt they have inside info on trial data which is blinded.
What they know is they own 20 million shares at a cost basis much lower who risk losing profits if there's no plan post data results. Only emergency use will rally the shares. An expensive phase 3 lasting until mid to late 2022 will not move the needle... Poor data and it's all time lows... Successful vaccines killed B's profit potential.
Yes, I'm a bag-holder who dranked the Leo Kool-Aid... This was back when CTIX had a chance to develop into something but the pretend CEO buried 3 promising compounds into the ground. It's a lottery ticket at-this-point... Follow the funding and hiring history... The biggest clues...
They have 10 to 12 more weeks to gradually unload their position. Leo will issue the data lock PR in late July which will give everyone a chance to get out... Only the IPIX bag-holders will remain... If Leo was confident in a post trial strategy he'd have interim data for 60 subjects... Drag out the suspense another 3 months.
The 3-day no volume rally has finally reached it's limit. Back to the teens by this afternoon as Kips unload some inventory... No reason to hold 20 million shares with a good chance of seeing this trade back to 6 pennies after data results. They have a nice buffer to unload here.
If someone issues many press releases touting an event that never lives up to the hype where financial reward is gained on the losses of others it surely is a scam operation... Leo's last chance to prove the naysayers wrong is August's judgment day. B for C has surpassed even Prurisol and OM for the drama build...
Kips Bay thrown a bone at .20 to slowly sell.
You guys spoke too soon, back to the teens... Lets see this rally back over .40... .20 is pathetic to even discuss.
Are you paying for Phase 3? Let's hope B gets emergency use or it won't matter... There's zero chance anyone will fork up 30 to 50 million for P3 that might take a year for results... The earliest would start is Fall or Winter... There's no money to be made with a late 2022 approval...
Getting better .20 held 30 minutes....
If Leo wanted data early he had a chance... 60 patients should be almost cleared the 29 day post assessment... Why he chose to delay data for 12 more weeks is his call... The window keeps shrinking as the vaccines prove effective... The only route that makes sense now is emergency use. A phase 3 will be too costly and take 8 to 12 months to recruit and run... 6 months for B phase 2 is a prime example...
India granted emergency use for Roche a few weeks back... Cmon Leo, focus on India now not Russia...
https://www.news18.com/news/india/india-approves-rocheregeneron-drug-for-covid-19-3710054.html
Running Clinical Trials in India... Leo needs to investigate this route...
https://credevo.com/articles/2018/01/10/india-is-ready-for-your-clinical-trials-are-you/
If naked shorting goes on with many stocks then why aren't they all trading at 19 pennies? Bogus excuse for not living up to the hype.
When does Kips Bay start dumping 20 million? It would be suicide holding that many shares into results... Their cost basis is still a gift selling at .19.... You'll start to see volume increase in July with a slow drip down to 10 pennies. No chance 400 million shares outstanding are staying put..
12 cent gain since this all started out 15 months ago... Some think this is due to rise? LOL Let's hope so further decline would be zero.
Expecting and receiving we'll know come August... There was a CV top 100 compound study/report, many above IPIX failed and never amounted to much... The lab results appear great but they have to be verified in humans... 120 may not be efficient enough to be approved.... A costly, long phase 3 will most likely not occur... It's emergency use by the FDA or a desperate Country to save Leo...
It’s not IPIX it’s Leo Pharma. Leo and sidekick Jane. Amazed how some still believe Innovation Pharma is a company or business?
As long as high risk are vaccinated those who get the virus will have no need for B... The fear put out by officials was overdone and now they can't let it go...
ML article on low prices securities.....
https://www.advisorhub.com/merrill-lynch-cracks-down-on-penny-stock-trades/
Open a ML or Bank of America account and let us know if you can buy IPIX or call them if you like?
Prurisol was another event with a similar pattern to B for C. I'm sure if one viewed the IHUB archives there would the same posts about Leo feeling confident... With the all the hype it better not miss like P...
Merrill Lynch banned low priced equities months ago... IPIX is on their list...
If Leo wanted data for 60 subjects interim results would be known soon. It's going to be August for final results... Clinical site chatter is just that...
Depends on what's success? They've never failed a B trial and still trade 19 pennies... Even if results are good/great the accountant still has to sell the data to others for success.
Volume is pathetic to break .20... There's no reason to buy shares unless someone wants to flip upper .19's and accumulate low .18's... Leo hasn't produced a catalyst to rally.
There's a post observation period of 29 days, since there's few subjects they'll wait until the last observation is completed. Early August will be the data lock... Shame, interim for 60 would be finishing up soon...
Time to sustained recovery through Day 29 [ Time Frame: Day 1 through Day 29 ]
Day of recovery is defined as the first day on which the subject satisfies one of the following three categories from the ordinal scale with response sustained through Day 29:
Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care (other than for per protocol dosing or assessments, as appropriate);
Not hospitalized, limitation on activities and/or requiring home oxygen;
Not hospitalized, no limitations on activities.
If trading follows yesterday's pattern will start the decline soon.
Data release will be another 4 or 5 weeks after subject 120... There's a post 29 day observation built into the trial... 70 percent of 120 is 84, so IPIX is averaging 8 recruits per/week... Guessing trial completion in 6 weeks,results in August. Emergency use will be the key driver if results are good/great. Phase 3 will be too long await to be worth the costs.
One day? Would they risk only 24 hours to kill the Virus? Once safety at 3 days passed the short test it made sense to move to 5...They'll have a few subjects with 3 and the rest 5...
There's no such thing as a market order at any set price. Anyone would be foolish to use market orders for IPIX...
There's surely a pattern of hyping an event at the shareholder's expense. Gold standard, how many press releases on CV19 since March 2020? No communications by board of director minutes or shareholder meetings? No update on major projects until crunch time surfaces. Zero information on Kips or the Aspire agreements when Leo always provided press releases before... Comparing B to C with other compounds on a regular basis... Email alerts on Sunday that was duplicate to a prior PR? All to sell shares for crippling finance deals. It's one thing to make public Dr B's replacement known but how about a reason for not following through? Who is second in charge?
That is why holding shares past the data lock makes no sense... If results miss that's the ballgame... Nothing has changed once it was known a trial would take place... Leo has convinced very few to trust his pumped up PRs.
The last PR was about other projects the CEO left out the past 15 months. After seeing other Cv19 companies have lawsuits notice how fast he provided an update... Believe it's too late and if B to C fails there's plenty of ammunition for neglecting shareholder communications and holding zero board of director meetings. Like I said last week, he better have a good lawyer if they miss badly.
Rosen is eying the IPIX trial I'm sure... Leo's given them plenty of ammo if B for C flops...